SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,798,000 | +7.9% | 46,749 | -17.4% | 0.12% | +5.1% |
| Q1 2018 | $2,593,000 | +13.3% | 56,606 | -1.4% | 0.12% | +17.0% |
| Q4 2017 | $2,288,000 | -1.5% | 57,404 | -1.1% | 0.10% | -6.5% |
| Q3 2017 | $2,323,000 | -7.3% | 58,066 | -0.2% | 0.11% | -9.3% |
| Q2 2017 | $2,507,000 | -1.1% | 58,167 | -28.2% | 0.12% | 0.0% |
| Q1 2017 | $2,536,000 | +14.0% | 81,031 | -8.0% | 0.12% | +12.4% |
| Q4 2016 | $2,224,000 | +1.0% | 88,078 | -1.1% | 0.10% | -0.9% |
| Q3 2016 | $2,202,000 | +3.7% | 89,024 | -14.6% | 0.11% | +12.8% |
| Q2 2016 | $2,124,000 | +59.5% | 104,257 | +19.4% | 0.09% | +56.7% |
| Q1 2016 | $1,332,000 | – | 87,345 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |